Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599570 · ClinicalTrials.gov registry record · NA
The STOP-HPV Trial 2: Performance Feedback Intervention
A NA study of Vaccination and Immunization, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT03599570: Completed NA study of Vaccination and Immunization, sponsored by University of California, Los Angeles.
NCT03599570 is a NA study of Vaccination and Immunization that has completed, run by University of California, Los Angeles. The registered enrollment target is 48 participants, below the 10,229-participant average among 12 other Vaccination trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03599570, a NA study of Vaccination and Immunization, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This cluster randomized clinical trial (RCT) will test the effectiveness (and cost-effectiveness) of the addition of performance feedback (period 2) to training providers previously received on HPV vaccine communication (period 1) to reduce MOs and increase HPV vaccination rates.
Primary Outcome
Change in the rate of missed vaccination opportunities from baseline (period 0) through the end of period 2 among all clinicians, with a focus on the contrast between the end of period 1 and period 2.
Conditions Studied
Interventions
- BEHAVIORAL STOP-HPV performance feedback intervention
Study Locations (1)
Illinois
- American Academy of Pediatrics - Itasca
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2018-08-07 |
| Est. Completion | 2020-03-06 |
| Phase | NA |
What the finished NCT03599570 record still lists
NCT03599570 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 10,229-participant average among 12 other Vaccination trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Vaccination appearing as the primary indexed condition, and to 1 intervention - of which STOP-HPV performance feedback intervention is the first listed.
NCT03599570 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03599570 about?
NCT03599570 is a clinical study titled "The STOP-HPV Trial 2: Performance Feedback Intervention". Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This cluster randomized clinical trial (RCT) will test the effectiveness (and cost-effectivenes...
What is the current status of trial NCT03599570?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-08-07. Estimated completion is 2020-03-06.
What conditions does trial NCT03599570 study?
This clinical trial studies the following conditions: Vaccination, Immunization.
What interventions are being tested in trial NCT03599570?
The interventions under investigation include: STOP-HPV performance feedback intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03599570?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03599570 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03599570's enrollment target sits among peer trials
48 11th of 12 higher than 2 of 12 other Vaccination trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaccination trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
RECRUITING · NA
-
"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
RECRUITING · NA
-
ARISe at UMass Chan
RECRUITING · NA
-
Kaiser Colorado Flu Nudge
ACTIVE NOT RECRUITING · NA
-
Text Message Reminder-Recalls For Early Childhood Vaccination
COMPLETED · NA
-
P3+ Intervention Phase
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI